Hypertrophy and loss of podocytes in diabetic nephropathy

Internal Medicine

Volumn 48, Issue 18, 2009, Pages 1615-1620

  Miyauchi, Masaaki ^a   Toyoda, Masao ^a   Kobayashi, Keiko ^a   Abe, Makiko ^a   Kobayashi, Takako ^a   Kato, Mayuko ^a   Yamamoto, Naoyuki ^a   Kimura, Moritsugu ^a   Umezono, Tomoya ^a   Suzuki, Daisuke ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Podocyte hypertrophy; Podocyte loss

Indexed keywords

SYNAPTOPODIN; WT1 PROTEIN;

ADULT; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY HYPERTROPHY; MALE; PODOCYTE; PROTEIN BLOOD LEVEL; URINARY EXCRETION;

ADULT; CASE-CONTROL STUDIES; CELL COUNT; CELL ENLARGEMENT; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR MESANGIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PODOCYTES; WT1 PROTEINS;

EID: 70349487338     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2137     Document Type: Article

References (23)

1. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997.
2. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344, 1999.
3. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic Nephropathy Study Group. Glomerular cell number in normal subjects and in type I diabetic patients. Kidney Ent 59: 2104-2113, 2001.
4. White KE, Bilous RW, Marshall SM, et al; The European Study for the Prevention of Renal Disease in Type I diabetes (ESPRIT). Podocyte number in normotensive type I diabetic patients with albuminuria. Diabetes 51: 3083-3089, 2002.
5. Dalla Vestra W, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nahropathy?. Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035, 2003.
6. Mundel P, Shankland SJ. Podocyte biology and response to injury J Am Soc Nephrol 13: 3005-3015, 2002.
7. Hoshi S, Shu Y, Yoshida F, et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 82: 25-35, 2002.
8. Natoli TA, Liu J, Eremina V, et al. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 13: 2058-2067, 2002.
9. Srichai MB, Konieczkowski M, Padiyar A, et al. A WT1 coregulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 279: 14398-14408, 2004.
10. Mundel P, Heid HW, Mundel TM, Kruger M, Reisor J, Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139: 193-204, 1997.
11. Menini S, Iacobini, C. Oddi G, et al. Increased glomerular cel (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 50: 2591-2599, 2007.
12. Kriz W, Krotzler M, Nagata M, et al. A frequent pathyway to glomerulosclerosis: Deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res 19: 245-253, 1996.
13. Kim YH, Goyal M, Kurnit D, et al. Podocyte depletion and glomendosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001.
14. Shirato I, Hosser H, Kimura K, et al. The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage. Virchow Arch 429: 255-273, 1996.
15. Lemley KV, Lafayette RA, Safari M, et al. Podocytepenia and disease activity in IgA nephropathy. Kidney Int 61: 1475-1485, 2002.
16. Kritz W, Gretz N, Lemley KV. Progression of glomerular disease: is the podocyte the culprit? Kidney Int 54: 687-697, 1998.
17. Kritz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microse Res Tech 57: 189-195, 2002.
18. Kritz W. Progressive renal failure - inability of podocytes to replicate and the consequences for development of gomerulosclerosis. Nephrol Dial Transplant 11: 1738-1742, 1996.
19. Kihara I, Yaoita E, Kawasaki K, Yamamoto T. Limitations of podocyte adaptation for glomerular injury in puromycin amino-nucleoside nephrosis. Pathol Int 45: 625-634, 1995.
20. Wiggins JE, Goyal M, Sanden SK, et al. Podocyte hypertrophy, "Adaptation," and "Decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: Prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005.
21. Pettermann AT, Pippin J, Durvasula R. Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 67: 157-166, 2005.
22. Kim NH, Rincon-Choles H, Bhandari B, Choudhury GG, Abboud HE, Gorin Y. Redox dependence of glomerular epithelial cell hypertrophy in response to glucose. Am J Physiol Renal Physiol 290: 741-751, 2006.
23. Makino H, Nakayama Y, Wada J. Remission and regression of diabetic nephropathy. Hypertension Res 26: 515-519, 2003.